Outpatient Control-to-Range: System and Monitoring Testing

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Outpatient Control-to-Range

Subjects will spend two nights (\~42 hours) in a local hotel during which the AP Platform will be remotely monitored in an adjacent hotel room for validation that remote system monitoring can successfully occur.

Trial Locations (2)

22904

University of Virginia, Charlottesville

93105

Sansum Diabetes Research Institute, Santa Barbara

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

University of California, Santa Barbara

OTHER

lead

University of Virginia

OTHER

NCT01578980 - Outpatient Control-to-Range: System and Monitoring Testing | Biotech Hunter | Biotech Hunter